Breaking News, Collaborations & Alliances

ImmunoQure & Servier Enter Partnership

For the development of a therapeutic autoantibody neutralizing interferon-alpha

ImmunoQure and Servier announced the establishment of a Worldwide, exclusive partnership for the development of a therapeutic autoantibody neutralizing interferon-alpha.   The companies will work collaboratively to advance ImmunoQure’s therapeutic human Interferon-alpha autoantibody through preclinical development and into the clinic, where Servier will assume all responsibilities for its development as therapeutic to treat diseases driven by elevated levels of interferon-alpha, wi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters